Etiology of Infectious Complications and Antibiotic-Resistance of Major Causative Agents in Victims with Severe Injury

Objective: to analyze the spectrum of major pathogens of infectious complications in patients with concomitant injury.

Materials and methods. 560 biological samples taken from 331 patients were bacteriologically studied. A significant reduction in the isolation frequency of Pseudomonas aeruginosa and an increase in etiological role of Staphylococcus aureus were ascertained in victims with severe injury and concomitant infectious complications during long-term 1982—1984 and 2002—2004 follow-ups.

Results. The significant pathogens of infectious complications in concomitant injuries are Staphylococcus aureus, Klebsiella and Escherichia coli. Vancomycin, imipenem/cilastatin, and amikacin are shown to be the most effective drugs for early antibiotic therapy. Thus, the findings reflect structural changes in the leading causative agents of infectious complications in victims with severe injury. If their principal pathogen was Pseudomonas aeruginosa in the 1990s, Staphylococcus aureus and representatives in the colibacillus group prevail today. This supports and generates a need for continuous microbiological monitoring of the causative agents of pyoin-flammatory complications in intensive care units wherein patients with immunosuppression are also present. Pathogen monitoring makes it possible to apply of a well-grounded and rational package of preventive and therapeutic measures and to perform early target antibiotic therapy.

1. Bouderka M. A., Bouaggad A., Sahib A. et al. Epidemiologic and prognostic aspects of nosocomial bacteriemia in the intensive care unit. Tunis Med. 2002; 80 (4): 188—192.

2. Bertrand X., Thouverez M., Talon D. at al. Endemicity molecular diversity and colonization routs of Pseudomonas aeruginosa in intensive care unit J. Intens. Care Med. 2001; 27: 1263—1268.

3. ErbayH., Valcin A. N., Serin S. et al. Nosocomial infections in intensive care unit in a Turkisy University hospital: a 2 year survey. Intens. Care Med. 2003; 29: 1482—1488.

4. Oncul O., Keskin O., Accar H. V. et al. Hospital acquired infections following the 1999 Marmara Earthquake. J. Hosp. Infections 2002; 51 (1): 47—51.

5. Raymond D. P., Pelletier S. J., Grabtree T. D. et al. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospital patients. Crit. Care Med. 2003; 31 (4): 1035—1041.

6. Thuong M., Arvaniti K., Ruimy R. et al. 2003 Epidemiology of Pseudomonas aeruginosa and risk factors for carriagea acquisition in an intensive care unit. J. Hosp. Ifect. 2003; 53 (4): 274—282.

7. Diouf E., Diop A. K., Beye M. D. et al. Acquired bacteraemias at the intensive care unit. Dakar Med. 2003; 48 (1): 34—40.

8. Bonten M. J., Bergmans D. C., Speijer H. at al. Charactiristics of polyclonal endemicity of colonization in intensive care units. Implications for infections control. Am. J. Respir. Crit. Care Med. 1999; 160: 1212—1219.

9. Engelhart D., Fuhr H. -G., Mller E. at al. Nosocomial Pneumonie. Stuttgart — N.-Y.; 1994.

10. Gruner E., Kropec A., Yuebner J. et al. Ribotyping of Pseudomonas aeruginosa strains isolated from surgical intensive care patients. J. Infect. Dis; 167: 1216—1220.

11. Langer M., Caretto E., Haeusler E. A. Infection control in ICU: back (forward) to surveillance samples? Intens. Care Med. 2001; 27: 1561—1563.